NDTDI

Chemical compound
  • Illegal in Latvia
Identifiers
  • N,N-diethyl-3-(methyl(1,3,4,5-tetrahydrobenzo[cd]indol-4-yl)amino)propanamide
PubChem CID
  • 163192742
CompTox Dashboard (EPA)
  • DTXSID601342245 Edit this at Wikidata
Chemical and physical dataFormulaC19H27N3OMolar mass313.445 g·mol−13D model (JSmol)
  • Interactive image
  • CCN(CC)C(=O)CCN(C)C1Cc3cccc2ncc(C1)c23

NDTDI is a tricyclic tryptamine derivative which is thought to act as a serotonin receptor agonist, though its pharmacology has not been studied in detail. It is a structurally simplified analogue of LSD and is reported to retain similar effects, though with many times lower potency. It has been sold as a designer drug since 2016 and was first identified by a forensic laboratory in Slovenia in 2017.[1]

Legality

NDTDI was made illegal in Latvia in March 2017.[2]

See also

  • 4,5-DHP-DMT
  • Bay R 1531
  • RU-28306
  • RU-24,969

References

  1. ^ Analytical Report: NDTDI. Nacionalni Forenzični Laboratorij, Slovenia, June 2017
  2. ^ Par aizlieguma noteikšanu vielai NDTDI un tās saturošiem izstrādājumiem.
  • v
  • t
  • e
Serotonin receptor modulators
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
  • See also: Receptor/signaling modulators
  • Adrenergics
  • Dopaminergics
  • Melatonergics
  • Monoamine reuptake inhibitors and releasing agents
  • Monoamine metabolism modulators
  • Monoamine neurotoxins
  • v
  • t
  • e